Skip navigation

Increase Transparency, Benchmark Risk and Reduce Disparity in Practice

April 30-May 1, 2019
  • Philadelphia, PA

CBI’s 6th Annual FMV Congress promotes a deeper understanding of the risk factors when establishing compliant FMV programs and processes within the life sciences industry. This comprehensive conference addresses critical challenges in harmonizing clinical and post-approval FMV practices, strategizing for success with bona fide fee-for-service agreements and keeping up with evolving requirements and regulations related to FMV. This forum also provides an opportunity to benchmark against your peers, learn about FMV best practices and participate in interactive and compelling discussions with industry experts.

Key Insights Include:

  • Harmonize FMV processes across clinical and commercial activities
  • New strategies for FMV calculations for HCPs, patient advocates and other critical stakeholders
  • How to calculate FMV appropriately for bona fide fee-for-service agreements
  • Risk management and compliance monitoring for FMV programs
  • Strategies for communicating with, and educating, HCPs and other FMV stakeholders on strategies for HCP educators and communications

Previous Attendee Acclaim:

This was a great opportunity to network and share
best practices in our very specialized field.

Finance Manager, Janssen Pharmaceuticals

Wonderful opportunity to meet/discuss with
colleagues and industry consultants.

Associate Director, Compliance Officer, R&D and FMV, Sanofi-Genzyme

A smaller conference setting was very condusive to
detailed discussion and the opportunity to have
individual questions answered.

HCP Request Operations Manager, Novo Nordisk

I learned a number of strategies that I’ll suggest to be implemented in my organization’s current FMV process.

IIS Coordinator, UCB Inc.

Great to hear and understand similar issues being faced/addressed within the industry.

Fee for Service Manager, GSK

6th Annual FMV Congress

Increase Transparency, Benchmark Risk and Reduce Disparity in Practice

CBI’s 6th Annual FMV Congress promotes a deeper understanding of the risk factors when establishing compliant FMV programs and processes within the life sciences industry. This comprehensive conference addresses critical challenges in harmonizing clinical and post-approval FMV practices, strategizing for success with bona fide fee-for-service agreements and keeping up with evolving requirements and regulations related to FMV. This forum also provides an opportunity to benchmark against your peers, learn about FMV best practices and participate in interactive and compelling discussions with industry experts.

Key Insights Include:

  • Harmonize FMV processes across clinical and commercial activities
  • New strategies for FMV calculations for HCPs, patient advocates and other critical stakeholders
  • How to calculate FMV appropriately for bona fide fee-for-service agreements
  • Risk management and compliance monitoring for FMV programs
  • Strategies for communicating with, and educating, HCPs and other FMV stakeholders on strategies for HCP educators and communications

Previous Attendee Acclaim:

This was a great opportunity to network and share
best practices in our very specialized field.

Finance Manager, Janssen Pharmaceuticals

Wonderful opportunity to meet/discuss with
colleagues and industry consultants.

Associate Director, Compliance Officer, R&D and FMV, Sanofi-Genzyme

A smaller conference setting was very condusive to
detailed discussion and the opportunity to have
individual questions answered.

HCP Request Operations Manager, Novo Nordisk

I learned a number of strategies that I’ll suggest to be implemented in my organization’s current FMV process.

IIS Coordinator, UCB Inc.

Great to hear and understand similar issues being faced/addressed within the industry.

Fee for Service Manager, GSK